In contrast to RAW264.7, MQ treatment of B16 cells led to a decrease in c-Myc but similar levels of phosphorylated p38, suggesting distinct SASP regulation in the RAW264.7 macrophage and B16 melanoma cell lines. This evidence concerns the gene MAPK14 and melanoma.